The 20 Best Immune Thrombocytopenic Purpura (ITP) Doctors Near Me in Charleston, SC

Dr. Charles Greenberg practices medicine in the area of nonmalignant blood disorders. He provides consultative advice regarding the diagnosis and treatment of bleeding, thrombosis, and disorders of blood cells. Dr. Greenberg conducts translational research regarding new diagnostic tests for management of bleeding and thrombotic disorders. Working in collaborations within the MUSC health care system he assists in management of blood, blood products, and the cost-effective management on nonmalignant blood disorders. Clinical research on the use new approaches to manage bleeding and thrombosis continue as part of national and international groups targeting life-threatening blood disorders. Dr. Greenberg's basic research is in the area of transglutaminase structure and function and he has published in the area of Factor XIII and tissue transglutaminase biology related to hemostasis, thrombosis, wound healing, angiogenesis, and tumor growth. Dr. Greenberg is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Pulmonary Embolism, Autoimmune Hemolytic Anemia, Antiphospholipid Syndrome, and Bone Marrow Aspiration.

"Benjamin Djulbegovic is a Professor of Medicine at the Medical University of South Carolina, Charleston, where he serves as a section Chief of Benign Hematology and Director of the Hematology Stewardship Program. His primary academic and research interest lies in attempts to measure and optimize clinical research and practice of medicine by understanding the nature of medical evidence and decision-making. To this effect, his work aims to close the translational research circle by integrating methods and techniques across evidence-based medicine (EBM), predictive analytics, health outcome research, and decision sciences with the goals of reducing overuse, underuse, and misuse of delivery of health services to improve patients' health outcomes.Dr. Djulbegovic has systematically applied the science of EBM and decision analysis to the entire fields of hematology and oncology that, resulted in two books; the book on ""Reasoning and decision-making in hematology"" was listed as one of the best books by J Natl Cancer Inst and the book ""Decision Making in Oncology. Evidence-based management"" was assessed as ""one of the first and best attempts to apply an evidence-based approach to the practice of medical oncology.""As of April 2022, he has published over 400 papers in peer-review journals, 196 abstracts, and numerous book chapters. He also received numerous awards for his work, published in major scientific and medical journals, including Nature, Lancet, JAMA, New England Journal of Medicine, Annals of Internal Medicine, BMJ, etc. He has also widely taught these subjects. During the last 25 years, Dr. Djulbegovic has received continuous external funding from federal and private entities. He was also selected in Newsweek's list of Top Cancer Doctors and, since 2011 continuously been selected among 1% of top US doctors by the US News \& World Report in the field of hematology. His current h-index is 72, and he has been regularly included in the top 1% cited scientists worldwide.". Dr. Djulbegovic is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Febrile Neutropenia, Venous Thromboembolism (VTE), Multiple Myeloma, and Thrombocytopenia.

Dr. Daniel Landau is a board certified Hematologist/Oncologist. He has been in practice since 2011. Dr. Landau obtained his medical degree and residency from the University of South Florida College of Medicine and then completed his hematology/oncology fellowship at the Orlando Health Cancer Institute (previously a part of MD Anderson). Dr. Landau's has been at the forefront of managing both benign and malignant conditions. He has also served in a number of roles beyond being a clinician including the institution of a telehealth service within Orlando Health. He now joins MUSC in a telehealth role. Dr. Landau has also provided a major role in medical education, having trained physicians for more than a decade. Dr. Landau has been published/ presented research within the New England Journal of Medicine, American Society of Clinical Oncology and American society of Hematology. Dr. Landau is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Familial Prostate Cancer, Multiple Myeloma, and Bone Marrow Aspiration.

Anthony Dominick, D.O., was born and raised in Kansas City before moving to Chicago, IL, to earn his Bachelor of Science in Biology at Loyola University. He received his medical degree from Lake Erie College of Osteopathic Medicine in Bradenton, FL. He then moved back to his hometown of Kansas City to complete his residency in internal medicine and fellowship in hematology and oncology at The University of Kansas Medical Center. Early on in his training, he was inspired by his mentors and developed a passion for malignant hematology. After completing training, he spent four years in private practice caring for patients with hematologic conditions in eastern North Carolina. He joined MUSC to pursue his interest and passion for caring for patients with multiple myeloma. He also has a secondary clinical interest in lymphoproliferative disorders. Dr. Dominick is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Dr. Steven Akman has been practicing hematology-oncology for more than 43 years. During his long career, he has taken care of patients with a range of non-malignant hematologic conditions, malignant hematologic conditions, and solid tumors. His area of emphasis has been in the medical oncologic management of breast cancer. He directed the Breast Cancer Center of Excellence of the Wake Forest University Comprehensive Cancer Center for 17 years.His wealth of experience allows him to bring maturity, patience, insight, and empathy to every patient interaction. He plans to spend the next five years taking care of hematology/oncology patients in the outpatient setting. His goal is to provide every patient with the highest possible quality of care and the educational and emotional support required for an effective partnership. Providing the highest possible quality of care includes the opportunity to provide access to clinical trials. Dr. Akman is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Breast Cancer, Lung Cancer, and Iron Deficiency Anemia.

Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Orchiectomy.

Dr. Kevin Becker is a medical oncologist who cares for patients with genitourinary cancers, including prostate, kidney and bladder. Dr. Becker received his medical degree from Columbia University College of Physicians and Surgeons in 2004. He completed an Internal Medicine residency and a Hematology and Oncology fellowship at New York Presbyterian/Columbia University Medical Center. In 2020, he received a Master of Medical Management degree from Carnegie Mellon University. He completed the Northwell Health Physician Leadership Development Program in 2021. Dr. Becker's research aims to expand and improve treatment options through cancer treatment clinical trials.Before joining MUSC, Dr. Becker was the Medical Director of the Maimonides Cancer Center in Brooklyn, New York, and Chief of the Regional Division of Hematology and Oncology for Maimonides and Downstate Health Sciences University. Dr. Becker is the Director of Oncology Infusion and Ambulatory Services at MUSC Hollings Cancer Center. Dr. Becker is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Clear Cell Sarcoma, and Familial Wilms Tumor 2.

Ashley Eason, MD, specializes in Pediatric Cancer and is located in Charleston, SC. Dr. Eason is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hemophilia A, and Hemophilic Arthropathy.

Anca Dumitriu, MD, specializes in Pediatric Cancer, and Pediatric Hematology/Oncology and is located in Charleston, SC. Dr. Dumitriu is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Neuroblastoma, and Hereditary Neuroblastoma.

Dr. Michelle Hudspeth is a 1999 graduate of the MUSC College of Medicine and completed her residency, chief residency, and fellowship at the Johns Hopkins Hospital and the National Cancer Institute. She is the division chief for pediatric hematology/oncology and is the director of the pediatric blood and marrow transplant program and the quality director for the combined adult and pediatric blood and marrow transplant program. Her main clinical focus is transplantation, including haploidentical, related and unrelated allogeneic, cord blood, and autologous donor sources. She is the institutional principal investigator for Pediatric Blood and Marrow Transplant Consortium trials. She is a member of the Pediatric Blood and Marrow Transplant Consortium GVHD committee and supportive care committee. She also serves on several working committees (GVHD, pediatric cancer, immune deficiencies/inborn errors of metabolism) for the Center for International Blood and Marrow Transplant Research. Her clinical research includes multiple aspects of transplantation, including a clinical trial incorporating pravastatin for matched related donor transplants for sickle cell disease. Dr. Hudspeth is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Infantile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Thymectomy.

Christopher Ferrante is a Pediatrics provider in Charleston, South Carolina. His top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Osama Abuhasheesh is a Pediatrics provider in Charleston, South Carolina. His top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Shayla Bergmann is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Bergmann is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, and Hemolytic Anemia.

Sherron Jackson is a Hematologist and an Oncologist in Charleston, South Carolina. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Jenny Riley is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Riley is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Breast Cancer, and Paget Disease of the Breast.

Jennifer Jaroscak is an Oncologist in Charleston, South Carolina. Dr. Jaroscak is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Anemia, Hemolytic Anemia, Hemoglobinopathy, and Bone Marrow Transplant.

Jacqueline Kraveka is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Kraveka is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Sickle Cell Disease, and Acute Lymphoblastic Leukemia (ALL).

Amy Bredlau is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Bredlau is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Brain Stem Cancer, Glioma, and Immune Thrombocytopenic Purpura (ITP).

Miguel Abboud is a Hematologist and an Oncologist in Charleston, South Carolina. His top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Sandeepkumar Kuril is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Kuril is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, and Acute Lymphoblastic Leukemia (ALL).